HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nestlé Broadens Supplements Offering In Brazil With Puravida Acquisition

Executive Summary

Nestlé Health Science is expanding its offering in Brazil with the acquisition of dietary supplements and nutritional products player Puravida.

You may also be interested in...



Nestlé Health Science Beats Expectations In Q1

Nestlé Health Science beat management's expectations in Q1 to post a solid organic sales rise despite facing a high comparative with the prior-year period. While Nestlé's group-wide sales were up in the three months, CEO Mark Schneider warned that further price rises were coming down the track, which would inevitably impact consumer spending.

EU Business News: Nestlé Acquires PronoKal, Bionorica Names International Head, Venture Life Gets New Partner

Round-up of the latest European consumer health industry news: Nestle Health Science has expanded its offering with the acquisition of weight management solution PronoKal; Germany's Bionorica has hired a new international business head; and the UK's Venture Life has appointed a Chinese distributor to grow sales of two of its key brands.

Nestle Harvests Plant-Based Protein Firm Orgain As Latest US Nutrition Business Investment

Nestle Health Science has expanded its nutritional footprint steadily since 2017 but investing in Orgain, with option to fully acquire in 2024 brings its first business working exclusively with plant-based ingredients.

Topics

Latest News
UsernamePublicRestriction

Register

RS152556

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel